How to Avoid AI Theater

Every company now has an AI story, and many have little else. AI theater is the gap between what is announced and what runs in production with a measured result behind it. This guide gives executives the diagnostic signs, the incentives that produce theater, and the structural fixes that make evidence the only currency.

What does AI theater look like?

Theater	Progress
Number of pilots	Number of agents in production with owners
Demo day	Monthly evidence review
Tool adoption rate	Cost per task against baseline
Innovation lab	Platform team plus embedded engineers
"We are exploring AI across the business"	"Invoice cycle time fell from the baseline to the current figure; here is the trend"
Announcements	Autonomy decisions made on evidence
Vendor showcases	Evaluation pass rates on our own cases

The left column is not wrong in itself; some of it is a normal early phase. It becomes theater when it persists as the program's output and is reported as progress. FISTA's end of the AI pilot era essay describes the market-wide version of this pattern.

Why does it happen?

Because it is rewarded. Boards and markets respond to announcements. Pilots are cheap, fast, and visible. Adoption statistics are easy to grow. Production systems are slow, expose failures, and require unglamorous investment in evaluation, monitoring, and process redesign. When leadership rewards visibility and does not insist on evidence, teams produce visibility. Theater is an incentive failure, and the incentives are set at the top. The why AI pilots fail guide catalogs the project-level mechanics.

What is the diagnostic?

Three questions, asked of the whole program:

1. What is in production, with a named owner? Not piloted, not planned: running, handling real volume.
2. For each, what was the baseline and what is the current number?
3. What autonomy or funding decision was made on evidence last quarter?

A program that answers with numbers is producing. One that answers with slides, counts, or adjectives is performing. The how to hold teams accountable for AI outcomes guide gives the review structure that makes the questions routine.

What are the structural fixes?

Theater cannot be fixed by exhortation. It is fixed by changing what is required and rewarded:

• Baseline before funding. No AI project is approved without a measured baseline, a target, and two named owners.
• Evidence opens every review. Production metrics and evaluation results first; demos never as evidence.
• Funding follows proof. The next tranche depends on the last one's measured result.
• Cap the pilot portfolio. A small number of committed outcomes concentrates attention; breadth is earned.
• Recognize shipping and honest stopping. Reward the team that shipped and the owner who retired a failing agent on evidence.
• Report to the board in outcomes. If the board hears pilot counts, the program will produce pilots. The how to report AI progress to the board guide gives the alternative.

What about vendors and demos?

Vendors sell with demos, and demos are optimized inputs. The defense is evaluation: run the vendor's system on your own cases with known correct answers, and compare pass rates and cost per task. A vendor who will not be evaluated is selling theater. The how executives should evaluate an AI demo guide gives the questions to ask in the room.

Is experimentation theater?

No. Experiments with a hypothesis, a decision date, and a path to production are how companies learn. Theater is experimentation without a decision: pilots that are neither killed nor scaled, labs with no route to operations, and activity reported as achievement. The test is whether the experiment ends in a decision backed by evidence. The when to kill an AI project guide provides the criteria for the decision.

Why is real progress also better theater?

A company that can say "three agents in production, cycle time down against baseline, one agent retired on evidence, two autonomy increases approved this quarter" has a better story than one with thirty pilots, because it is believable and specific. The board, the market, and employees can all tell the difference. Substance is the most durable form of narrative.

What should executives ask?

• What is in production today, and what changed because of it?
• What baseline did each project have when it was funded?
• When did we last decline to fund a project for lack of a baseline?
• What did the board hear last quarter: outcomes or activity?
• Which pilots have neither been killed nor scaled in the last two quarters?

How can FISTA Solutions help?

FISTA Solutions builds for production: every AI agent engagement starts with a baseline, a target, and owners, and ends with a system running under supervision with evaluation and monitoring. Its Applied division helps executive teams convert pilot portfolios into committed outcomes with evidence. Since 2017, FISTA has delivered 150+ projects for 50+ companies across 12+ countries.

If your AI program has more pilots than production systems, talk to FISTA on WhatsApp about a portfolio review, or read the cost of AI that does not ship.